Society Response To Healthcare Commision Announcement The British Psychological Society has welcomed the
Healthcare Commission's announcement that it will visit 48 inpatient learning disability services to ensure their standards of care.
Source: www.medicalnewstoday.comSuicide Prevention May Be Broadened By Broaching Issue Of Access To Guns With Patients In an effort to create safer environments for potentially suicidal individuals, researchers at Harvard School of Public
Health demonstrate how physicians can broaden their treatment of such patients to address not only their mental illness but also the patients' access to guns and other lethal means. Such an approach could dramatically reduce suicide fatalities.
Source: www.medicalnewstoday.comAdolescents From Certain Races Participating In Religion May Become More Depressed One of the few studies to look at the effects of religious participation on the mental
health of minorities suggests that for some of them, religion may actually be contributing to adolescent depression. Previous research has shown that teens who are active in religious services are depressed less often because it provides these adolescents with social support and a sense of belonging.
Source: www.medicalnewstoday.comMaternity Safety In Practice Seminar (RCM Accredited) Working In High-Risk Situations, 20 October 2008, London Monday 20 October 2008, 9.30am-1.15pm The King's Fund, London The full programme for The King's Fund maternity safety in practice seminar on working in high-risk situations is available on our website.
Source: www.medicalnewstoday.comHospitalizations For Osteoarthritis Rising Sharply, USA Hospitalizations for osteoarthritis soared from about 322,000 in 1993 to 735,000 in 2006, according to the latest News and Numbers from the Agency for
Healthcare Research and Quality. Osteoarthritis is a painful disease resulting from deteriorating cartilage and bones rubbing together.
Source: www.medicalnewstoday.comQuatRx Initiates Second Phase 3 Study Of Ophena(TM) (Ospemifene Tablets) In Women With Postmenopausal Vaginal Syndrome QuatRx Pharmaceuticals, a privately-held biopharmaceutical company focused on development and commercialization of compounds to treat endocrine, metabolic and cardiovascular disorders, announced that it has initiated a second Phase 3 clinical trial of Ophena(TM) (ospemifene tablets), the company's estrogen-free oral therapy in development for the treatment of vaginal symptoms associated with menopause.
Source: www.medicalnewstoday.comInternational Team Reveals First Prognosticator Of Survival In Aggressive Cancer The tumor suppressor gene pRb2/p130 may provide the first independent prognostic biomarker in cases of soft tissue sarcoma (STS), according to an international collaboration of researchers, including scientists at the Sbarro Institute for Cancer Research and Molecular
Medicine at the College of
Source: www.medicalnewstoday.com
# posted by Network @ 9:00 AM
